Skip to main content
European Commission logo print header

Development of a safe, efficacious bluetongue virus vaccination strategy for europe (BLUETONGUE VACCINATION)

Objectif

Bluetongue virus (BTV) has a track record of incursion into the EU & causing severe disease & financial losses to our livestock industry. However, the EU has no coherent vaccination policy, which makes BTV incursions difficult or impossible to control. This project will enable an effective policy to be established for the first time by testing the existing live virus vaccines for efficacy & safety, & by providing clear science-based recommendations on their use or otherwise in Europe. The project will also seek to develop & produce inactivated vaccines conferring enhanced protection using state of the art technology with engineered "virus-like particles" & slow release delivery systems. In addition, by sequencing live vaccine strains of BTV & wild strains isolated in the field around Europe, database will be established to enable sourcing of European BTV incursions & early detection of vaccine breakdown thus facilitating targeting of control measures.

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts
æ

Coordinateur

INSTITUTE FOR ANIMAL HEALTH
Adresse
Ash road, nr woking
GU24 0NF Woking
Royaume-Uni

Voir sur la carte

Contribution de l’UE
Aucune donnée

Participants (4)